Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
abandonment, accommodative, Acrux, Affordable, aid, Alnara, amyloid, Amyvid, analogue, anemia, arm, ASU, austerity, Austria, Avid, Axiron, backdrop, bacteria, BAFF, basal, benign, blood, brain, build, Bydureon, calendar, captive, cardiac, center, Chase, cholesterol, Citibank, clear, cognition, cognitive, commented, competitor, concomitant, constant, constitutionality, desired, Deutsche, dictate, diffuse, Diversity, DMC, dose, dosing, doughnut, emission, Enfield, entirety, enzyme, EPI, erosion, estoppel, EU, exceptionally, excise, exocrine, experimental, feedback, florbetapir, Fry, gamma, gap, gastric, Gastrointestinal, gave, gemcitabine, gene, guarantor, Hague, Hatch, healthy, heart, hierarchy, highlighted, hole, hyperplasia, imaging, imposition, Indenture, INSPIRE, insufficiency, irrelevant, ischemic, lending, linagliptin, liprotamase, lymphoma, Manhattan, Master, meantime, melanoma, merger, met, metabolic, migrating, molecular, NAV, negligible, nonenforceability, norepinepherine, novelty, outlook, outpatient, outsource, overpricing, pace, panel, parallel, pathology, peptide, persistently, PET, plaque, play, Portugal, pose, positron, potent, precise, prejudice, priority, proceed, prostatic, prove, proven, radiopharmaceutical, reader, Reconcile, rely, remanded, remeasure, reply, reproducible, Resetable, Resettable, resigned, resubmission, reuptake, revoked, rhythm, rigorously, role, RSU, scan, screening, secretase, semagacestat, sick, slightly, Sligo, small, solution, sovereign, stable, stance, steady, Stephen, stream, streamline, subsidy, synthesize, tailored, tasisulam, testosterone, theft, theory, thromboembolism, tool, topography, toxicity, TRICARE, Trustee, twenty, unanticipated, underam, unproven, unresectable, unsuccessful, upholding, utero, warranted, worsening, Zypadhera®in
Removed:
acquiree, acquirer, administratively, aimed, alliance, antagonist, antineoplastic, Ariad, Biomedical, broader, capitalization, cellular, Coban, College, commenced, comprise, damage, deconsolidated, deconsolidation, direct, doctor, document, dosage, dual, EITF, enabled, estimating, exhausted, FDAAA, function, Glenmark, Harvard, humanized, Hypnion, illiquidity, Ind, India, inducing, inRule, Institute, insurer, issue, Ivy, jury, legalize, Mayne, mechanism, MMA, Modernization, natural, negotiate, nominally, nutrition, offsetting, ofRegulation, onForm, onset, Ontario, operational, OSI, osteoarthritic, passed, phenomenon, physiology, prepayment, presence, preventing, problem, promoting, pronouncement, publicity, Quebec, ratified, realize, recognizable, recoverability, Reddy, reexamination, reflecting, rejection, remediation, remote, retrospectively, revised, Sicor, signaling, Singapore, sleep, Task, Taurel, technological, thisForm, threshold, transient, veterinary, voluntary, Whitehead
Filing tables
Filing exhibits
- 10-K Annual report
- 10.8 the Eli Lilly and Company Bonus Plan, As Amended
- 10.14 Arrangement Regarding Severance for DR. Jan Lundberg
- 12 Statement Re: Computation of Ratio of Earnings (Loss) to Fixed Charges
- 21 List of Subsidiaries
- 23 Consent of Independent Registered Public Accounting Firm
- 31.1 Rule 13A-14(A) Certification of President and Chief Executive Officer
- 31.2 Rule 13A-14(A) Certification of Chief Financial Officer
- 32 Section 1350 Certification
Related press release
LLY similar filings
Filing view
External links